Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-05-25 @ 11:53 AM
Study NCT ID:
NCT04624633
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-27
First Post:
2020-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
Sponsor:
Jennifer R. Brown, MD, PhD
Organization:
Conditions & Keywords Data
Conditions: